To Top

Content Filter


1198 Articles available
Oncology

Device Plus Drug Approved for Bladder Cancer Detection

PAO-M02-18-NI-018
Acquisition

Novacap acquires interest in Mailhot Industries

PR-M02-18-NI-80
Drug Development

Evotec and MaRS Innovation Announce First Funded Project under LAB150 Bridge

PR-M02-18-NI-79
Antibiotic-Resistant

ABAC Therapeutics Announces €16 Million Series A to Develop Therapeutic Solutions to Fight Antibiotic-Resistant Bacteria

PR-M02-18-NI-78
FDA Approval

FDA approves new treatment for a certain type of prostate cancer using novel clinical trial endpoint

PR-M02-18-NI-77
Orphan Drug

Selumetinib Granted Orphan Drug Designation by the U.S. FDA for Neurofibromatosis Type 1

PR-M02-18-NI-76
Drug Development

Oxford BioMedica Completes Licensing Agreement with Bioverativ Inc.

Clinical Trials

Breakthrough Scar Treatment in Clinical Trials

PAO-M02-18-NI-016
Appointment

Marken Appoints New Vice President, Global Quality Assurance

PR-M02-18-NI-81
FDA

Ortho Dermatologics Announces U.S. FDA Filing Acceptance For JEMDEL™ Plaque Psoriasis Treatment

PR-M02-18-NI-75
Clinical Trials

Mallinckrodt Enrolls First Patient in Phase 1 Study of ExpressGraft™C9T1 Skin Tissue

PR-M02-18-NI-74
Breakthrough Therapy

Pfizer Receives Breakthrough Therapy Designation from FDA for PF-04965842

PR-M02-18-NI-72
Strategic Collaboration

Bristol-Myers Squibb and Nektar Therapeutics Announce Global Development & Commercialization Collaboration for Nektar’s CD122-biased Agonist, NKTR-214

PR-M02-18-NI-73
Approval

Celltrion Receives EU Approval for Trastuzumab Biosimilar

PR-M02-18-NI-71
Facility

Cytovance® Biologics, Inc. announces completion of first batch in new state-of-the-art 1000L microbial facility

PR-M02-18-NI-68
Appointment

Envigo appoints Lynn Lewis as Senior Vice President of Global Sales

PR-M02-18-NI-67
Acquisition

Mallinckrodt Completes Acquisition Of Sucampo Pharmaceuticals, Inc.

PR-M02-18-NI-62
Cell Culture Portfolio

Lonza Expands Cell-Culture Portfolio with Quasi Vivo ® System

PR-M02-18-NI-59
OEM

BioLife Solutions Executes OEM Agreement with MilliporeSigma

Appointment

Charles River Laboratories Announces Executive Management Appointments

PR-M02-18-NI-58
SCRS' Global Impact Partner Program

Boehringer Ingelheim Demonstrates their Commitment to Site Relationships by Joining SCRS' Global Impact Partner Program

PR-M02-18-NI-56
Dermatology

Sun Pharma Announces Twelve Tildrakizumab Abstracts to be Presented at American Academy of Dermatology 2018 Annual Meeting

PR-M02-18-NI-54
Strategic Collaboration

Sirenas Enters Into Multi-Target Collaboration With Bristol-Myers Squibb

PR-M02-18-NI-55
Inhalation

Teva Announces U.S. Launch of QVAR® RediHaler™ (Beclomethasone Dipropionate HFA) Inhalation Aerosol

PR-M02-18-NI-53
Priority Review

U.S., EU and Japan Health Authorities Accept Regulatory Submissions for Review of Pfizer’s Third-Generation ALK Inhibitor Lorlatinib

PR-M02-18-NI-52
Generics

The Path Toward Generics: 2017’s Record-Breaking Year

PAO-M02-18-NI-015
FDA

Label Update Approved for Novartis’ Cosentyx

PAO-M02-18-NI-014
Growth

Fueled by Growth, Alcami Unveils New Sales Office in Cambridge, MA

PR-M02-18-NI-63
Strategic Partnership

ImmunoQure AG and Servier Enter into Strategic Partnership for the Development of an Interferon-alpha Human Autoantibody

PR-M02-18-NI-64
Generics

Teva Announces Launch of a Generic Version of Syprine® in the United States

PR-M02-18-NI-050
Drug Development

WuXi Biologics Congratulates Tychan for Dosing First Patient of a Zika Antibody after Record 9 Months of Development

PR-M02-18-NI-049
FDA Approval

Pii and Its Partners Received FDA Market Approval for Seven Products and Commercially Launched 6 Products in 2017

PR-M02-18-NI-048
Strategic Partnership

Denali Therapeutics and Lonza Pharma & Biotech Announce Exclusive Partnership to Develop and Produce Biologic Medicines

PR-M02-18-NI-047
In Conversation

Behind the Scenes of International Pharmaceutical Business Success: A Conversation with Horst Wallrabe

PAO-M02-18-IC-001
Investment

China Invests Heavily in Western Biotech

PAO-M02-18-NI-013
Acquistion

Allergen Acquires Elastagen

PAO-M02-18-NI-012
Acquistion

Charles River Laboratories to Acquire MPI Research

PR-M02-18-NI-57
FDA Approval

Novartis receives FDA approval for Cosentyx® label update to include moderate to severe scalp psoriasis

PR-M02-18-NI-046
Drug Development

AbbVie receives a positive recommendation from the CADTH Canadian Drug Expert Committee for MAVIRET™

PR-M02-18-NI-044
Stem Cell

Royal Biologics Launches Amnio-Maxx™, a Stem Cell Product Derived From Human Amniotic Placental Tissue

PR-M02-18-NI-045
Clinical Trials

Encorafenib and Binimetinib Combination Treatment Demonstrates 33.6 Month Median Overall Survival (OS) in Patients with BRAF-Mutant Melanoma

PR-M02-18-NI-043
Launch

WuXi AppTec Launches Advanced Library Compound Initiative on LabNetwork.com

PR-M02-18-NI-039
Award

Thermo Fisher Scientific Wins CiteAb 2018 Award for its Antibody Validation Initiative

PR-M02-18-NI-040
Animal Health

Merial, Now Part of Boehringer Ingelheim, Grows Canine Vaccine Portfolio With Introduction of RECOMBITEK® Oral Bordetella

PR-M02-18-NI-038
Strategic Partnership

AbbVie and MBC BioLabs Team Up to Support Life-Science Startups in the San Francisco Bay Area

PR-M02-18-NI-037
Clinical Trials

Tyzivumab is Ready for Trials

PAO-M02-18-NI-011
Biomanufacturing

Amgen to Open Biomanufacturing Plant in the US

PAO-M02-18-NI-010
Packaging

SCHOTT AG, ARaymondlife and Vanrx Pharmasystems announce product compatibility for primary packaging of sterile injectables

PR-M02-18-NI-035
Marketing

Evonik Launches a New MetAMINO® Marketing Campaign to the Middle East and African Markets At VIV MEA in Abu Dhabi

PR-M02-18-NI-033
Launch

Thermo Fisher Scientific Launches Axiom Microbiome Array for Research

PR-M02-18-NI-032
Acquistion

Celanese Completes Omni Acquisition

PAO-M02-18-NI-009
Investment

Polpharma Group Gets Digital

PAO-M02-18-NI-008
CDMO

Grünenthal Group Receives FDA's Expedited Access Pathway Designation for VIVO

PR-M02-18-NI-030
Certification

Merck KGaA, Darmstadt, Germany certified as one of the Top Employers North America 2018

PR-M02-18-NI-028
Acquistion

Celgene Corporation Commences Tender Offer for Juno Therapeutics, Inc.

PR-M02-18-NI-026
Generic

Mylan Expands Access to HIV/AIDS Medicines with Launch of First Generic Sustiva® Tablets

PR-M02-18-NI-025
Appointment

PPD Names Maria Teresa Hilado, CFO of Allergan, to its Board of Directors

PR-M02-18-NI-023
Joint Venture

DSM and Evonik Establish Veramaris Joint Venture

PR-M02-18-NI-024
Innovation

Thermo Fisher Scientific Receives Manufacturing Leaders' Innovation Award

PR-M02-18-NI-023
Acquistion

Partner Therapeutics (PTx) Acquires Leukine® from Sanofi

PR-M02-18-NI-021
Market Expansion

Marken Accelerates Its Reach And Growth In Clinical Trial Logistics

PR-M02-18-NI-031
Investment

Dracen Pharmaceuticals Raises Over $40 million

PAO-M02-18-NI-007
Drug Development

Mylan and Theravance Will Receive FDA Decision on COPD Drug by November

PAO-M02-18-NI-006
Immuno-Oncology

Syndax Announces Immuno-Oncology Clinical Trial Collaboration with AstraZeneca

PR-M02-18-NI-020
CEO

Rentschler Biopharma SE Appoints International Biopharma Expert Dr. Ralf Otto as Chief Operating Officer

PR-M02-18-NI-018
Investment

Charles River Laboratories Makes Investments in High-Throughput Screening Infrastructure

PR-M02-18-NI-017
Leadership

Avara Pharmaceutical Services Wins CMO Leadership Awards in All 6 Categories for Contract Manufacturing

PR-M02-18-NI-016
Financing

Engine Biosciences Raises $10 Million in Seed Financing to Accelerate Drug Discovery Using Genomics and Artificial Intelligence

PR-M02-18-NI-015
Expanded Capacity

Cambrex Expands Process Research and Development Capabilities Across North America

PR-M02-18-NI-014
Contract

Prime Therapeutics and Boehringer Ingelheim Enter Into Outcomes-Based Contract for Jardiance®

PR-M02-18-NI-013
Staffing

Boehringer Ingelheim Announces Paul Fonteyne to Retire at the end of 2018

PR-M02-18-NI-012
IND Application

WuXi Biologics Congratulates BioAtla on FDA Clearance of IND Application for CAB-AXL-ADC

PR-M02-18-NI-011
Healthcare

Leading Companies Taking Action to Address Healthcare

PAO-M02-18-NI-005
Animal Nutrition

Versamaris JV Formed by DSM and Evonik

PAO-M02-18-NI-004
Oncology

Stand Up To Cancer Announces $11M Collaborative, Multi-Disciplinary Research Program

PR-M02-18-NI-010
Partnership

Agilent Partners with Science Exchange

PR-M02-18-NI-009
Discovery

Scientists Discover How Gene Mutation Triggers Immune Disease

PR-M02-18-NI-008
Strategic Collaboration

WuXi Biologics and Aravive Biologics to Form Strategic Manufacturing Collaboration Following Successful IND Filing for AVB-S6-500

PR-M02-18-NI-007
Agreement

BioDuro Announces Cooperation Agreement with Porton Pharma Solutions

PR-M02-18-NI-006
Clinical Trials

COPD Patients Excited about AstraZeneca Trial Results

PAO-M02-18-NI-002
Oncology

Stopping Cancer Cell Division Using Targeted Enzyme Control

PAO-M02-18-NI-001
Fast Track

FDA Grants Fast Track Status to Takeda’s Zika Vaccine Candidate

PAO-M02-18-NI-003
New Drug Application

Theravance Biopharma and Mylan Announce FDA Acceptance of New Drug Application for Revefenacin (TD-4208) in Adults with Chronic Obstructive Pulmonary Disease

PR-M02-18-NI-005
Distribution

Nexeo Solutions Announces New Distribution Agreement in Mexico for BASF Personal Care

PR-M02-18-NI-004
Vaccine

Takeda’s Zika Vaccine Candidate Receives U.S. FDA Fast Track Designation

PR-M02-18-NI-003
Laboratory

New, Automated UV-Visible Spectrophotometers are Designed for Today's Modern Lab

PR-M02-18-NI-002
Acquisition

CASI Pharmaceuticals Acquires ANDA Portfolio From Sandoz Inc. (Sandoz)

PR-M02-18-NI-001
Forecast

Biotechnology Companies Prepared for a Big 2018

PR-M01-18-NI-099
Oncology

Specific Protein Plays Key Role in the Spread of Breast Cancer

PR-M01-18-NI-098
Drug Development

New Real-World Analysis Finds Lower Risk of Major Bleeding and Similar Risk of Stroke with Standard Dose of Pradaxa® Compared to Rivaroxaban

PR-M01-18-NI-097
Acquistion

Novacap TMT Enters into Definitive Agreement to Acquire Horizon Telcom

PR-M01-18-NI-096
Drug Development

Janssen to Present 14 Abstracts in Prostate and Urothelial Cancers at ASCO GU 2018

PR-M01-18-NI-095
Biosimilars

Novartis Makes More Biosimilar Moves

PAO-M01-18-NI-047
Vaccine

EMA Committee Gives Positive Recommendation to GSK’s Shingles Vaccine

PAO-M01-18-NI-046
Acquistion

Sanofi Will Acquire Ablynx for €3.9 Billion

PAO-M01-18-NI-045
Wearable Devices

Wearable Medical Devices Market 18.3% CAGR to 2022

PR-M01-18-NI-094
Market Insight

Global Stroke Management Market Expected to Reach $36,756 million by 2023 — Allied Market Research

PR-M01-18-NI-092
Healthcare

Innovation in Telemedicine and mHealth Solutions Significantly Changing the Healthcare Industry

PR-M01-18-NI-091
Efficacy

Efficacy Testing Market Worth 501.6 Million USD by 2022

PR-M01-18-NI-090
Strategic Partnership

Biocartis & Immunexpress Sign Partnership for a Sepsis Host Immune Response Test on the Idylla™ platform

PR-M01-18-NI-094
Market Prediction

Focal Segmental Glomerulosclerosis Market to Reach US$15.83 Billion by 2025, Globally: Transparency Market Research

PR-M01-18-NI-093
Biosimilars

Pfizer Announces Positive Top-Line Results For Potential Biosimilar To Rituxan®/MabThera®

PR-M01-18-NI-092
Point-of-care

Point-of-care Diagnostics Market is Estimated to Register a CAGR of 6.9% by 2024, Globally: Transparency Market Research

PR-M01-18-NI-091
Licensing

Grace Licenses UNIPOL® PP Process Technology to Grupa Azoty in Poland

PR-M01-18-NI-090
CAR-T

Pfizer Joins Gilead in CAR-T Development   

PAO-M01-18-NI-044
FDA

FDA and DoD Launch Joint Program to Accelerate Drug Development

PAO-M01-18-NI-043
Strategic Partnership

WuXi Partners with Swedish Firm to Establish New Contract Manufacturer

PAO-M01-18-NI-043
Cell and Gene Therapy

Cell Therapy Companies Can Now Have Improved Cell Thawing Capabilities

PAO-M01-18-NI-042
Appointment

UPM Pharmaceuticals appoints Daniel Dixon as Vice President of Quality Control

PR-M01-18-NI-088
Capacity Expansion

Paragon Bioservices Announces New Commercial Manufacturing Facility Expansion

PR-M01-18-NI-087
Biosimilars

Sandoz - Biocon Deal One More Sign That U.S. Biosimilars Have Arrived

PR-M01-18-NI-086
Drug Discovery

X-Chem Enters Expanded Global Drug Discovery and Technology Transfer Collaboration with AstraZeneca

PR-M01-18-NI-073
Clinical Trial

Amgen and Novartis Reach an Important Milestone

PAO-M01-18-NI-041
Launch

GSK Launches Three-in-One HIV Pill in China

PAO-M01-18-NI-040
Acqusition

Celgene Confirms $9 Billion Buyout of Juno Therapeutics

PAO-M01-18-NI-039
Immuno-Oncology

European Commission Approves Bristol-Myers Squibb’s Yervoy (ipilimumab) for Treatment of Pediatric Patients 12 Years and Older with Unresectable or Metastatic Melanoma

PR-M01-18-NI-082
Oncology

Combination of Encorafenib, Binimetinib and Cetuximab Demonstrated an 8 Month Median Progression-Free Survival

PR-M01-18-NI-081
Approval

LYNPARZA® (olaparib) Receives Approval in Japan for the Treatment of Advanced Ovarian Cancer

PR-M01-18-NI-078
Investment

Contract Research Organization Growth and Investment

APR-M10-17-NI-001
Inhalation

Hovione strengthens Inhalation Services portfolio

PR-M01-18-NI-084
Biosimilar

European Commission Approves Amgen And Allergan's MVASI® (Biosimilar Bevacizumab) For The Treatment Of Certain Types Of Cancer

PR-M01-18-NI-077
Opening

Marken Opens New Location In Stuttgart, Germany

PR-M01-18-NI-083
//Fix for text overflow in cards